To investigate the upregulation-triggered effects of different autophagy genes on human breast cancer treatment, we extracted the RFS-based survival data of patients who have breast cancers with high- and low-levels of an autophagy gene associated with ERBB2-positive and -negative statuses in the Kaplan–Meier Plotter datasets. This evidence concerns the gene ERBB2 and breast carcinoma.